Increased Expression of IL-6 and LIF in the Hypertrophied Left Ventricle of TGR(mRen2)27 and SHR Rats

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2005 Mar 25

PMID 15786720

Citations 16

Authors

Mazen Kurdi

Jacques Randon

Catherine Cerutti

Giampiero Bricca

Affiliations

Soon will be listed here.

Abstract

Cytokines from the interleukin-6 (IL-6) family have been reported to play an important synergistic role with angiotensin II in the development of pathological cardiac hypertrophy. Whether their expression pattern changes in vivo, in an angiotensin I-dependent hypertrophied myocardium has not been reported. In this study, we addressed that issue using two animal models of angiotensin II-dependent cardiac hypertrophy. Heterozygous transgenic TGR(mRen2)27 (TGR) with an overactive cardiac renin angiotensin system and the closely related spontaneously hypertensive rats (SHR) were compared to their respective control rats. The mRNA levels of IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and cardiotrophin-1 (CT-1) as well as their receptor subunits, glycoprotein 130 (gp130), IL-6 receptor (IL-6R), LIFR, and CNTFR, were measured by semi-quantitative RT-PCR. The protein levels of IL-6, LIF and CT-1 were investigated by western blot. TGR and SHR both displayed significant over expression of mRNA and protein levels for IL-6 and LIF. In TGR, the increased level of LIF was accompanied by a decrease in mRNA levels for LIFR and CNTFR. In SHR, a higher level of mRNA IL-6R was observed. By contrast, the mRNA and protein levels for CT-1 and the mRNA level for gp130 did not vary in these two models. These findings suggest that IL-6 and LIF, but not CT-1, contribute to angiotensin II-dependent left ventricular hypertrophy in the two hypertensive rat models, TGR(mRen2)27 and SHR.

Citing Articles

The Role of Leukemia Inhibitory Factor in Cardiovascular Disease: Signaling in Inflammation, Coagulation, and Angiogenesis.

Rezaeeyan H, Moghimian-Boroujeni B, Abdolalian M, Javan M J Tehran Heart Cent. 2024; 19(1):6-13.

PMID: 39712364 PMC: 11659708. DOI: 10.18502/jthc.v19i1.15531.

ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats.

Kozlowska A, Wojtacha P, Rowniak M, Kolenkiewicz M, Huang A Psychopharmacology (Berl). 2019; 236(10):2937-2958.

PMID: 30737597 PMC: 6820808. DOI: 10.1007/s00213-019-5180-0.

Bioelectrical signals improve cardiac function and modify gene expression of extracellular matrix components.

Macfelda K, Kapeller B, Holly A, Podesser B, Losert U, Brandes K ESC Heart Fail. 2017; 4(3):291-300.

PMID: 28772035 PMC: 5542736. DOI: 10.1002/ehf2.12169.

Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis.

Li Y, Ge S, Peng Y, Chen X Burns Trauma. 2016; 1(3):109-21.

PMID: 27574633 PMC: 4978107. DOI: 10.4103/2321-3868.123072.

Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study.

Gupta J, Dominic E, Fink J, Ojo A, Barrows I, Reilly M PLoS One. 2015; 10(4):e0124772.

PMID: 25909952 PMC: 4409366. DOI: 10.1371/journal.pone.0124772.

References

Takimoto Y, Aoyama T, Iwanaga Y, Izumi T, Kihara Y, Pennica D . Increased expression of cardiotrophin-1 during ventricular remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol. 2002; 282(3):H896-901. DOI: 10.1152/ajpheart.00591.2001. View

Kurdi M, Dizerens N, Cerutti C, Bricca G, Randon J . [Expression of cytokines and their receptors in left ventricular hypertrophy in TGR(mRen2)27 rats]. Arch Mal Coeur Vaiss. 2003; 96(7-8):811-4. View

Wang F, Seta Y, Baumgarten G, Engel D, Sivasubramanian N, Mann D . Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart. Circulation. 2001; 103(9):1296-302. DOI: 10.1161/01.cir.103.9.1296. View

Fukuzawa J, Booz G, Hunt R, Shimizu N, Karoor V, Baker K . Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy. Hypertension. 2000; 35(6):1191-6. DOI: 10.1161/01.hyp.35.6.1191. View

Jurkovicova D, Dobesova Z, Kunes J, Krizanova O . Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats. Physiol Res. 2001; 50(1):35-42. View

Heinrich P, Behrmann I, Muller-Newen G, Schaper F, Graeve L . Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J. 1998; 334 ( Pt 2):297-314. PMC: 1219691. DOI: 10.1042/bj3340297. View

Ohta K, Kim S, Iwao H . Role of angiotensin-converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development. Hypertension. 1996; 28(4):627-34. DOI: 10.1161/01.hyp.28.4.627. View

Mizuno K, Tani M, Hashimoto S, NIIMURA S, Sanada H, Watanabe H . Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. Life Sci. 1992; 51(5):367-74. DOI: 10.1016/0024-3205(92)90589-h. View

Tone E, Kunisada K, Kumanogoh A, Negoro S, Funamoto M, Osugi T . gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. Cytokine. 2000; 12(10):1512-8. DOI: 10.1006/cyto.2000.0751. View

10.

Levy D, Garrison R, Savage D, Kannel W, CASTELLI W . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322(22):1561-6. DOI: 10.1056/NEJM199005313222203. View

11.

Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J . Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem. 2000; 275(38):29717-23. DOI: 10.1074/jbc.M003128200. View

12.

Dahlof B . The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy. J Hypertens Suppl. 1993; 11(3):S29-35. View

13.

Ohta K, Kim S, Wanibuchi H, Ganten D, Iwao H . Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats. Circulation. 1996; 94(4):785-91. DOI: 10.1161/01.cir.94.4.785. View

14.

Lee M, Bohm M, Paul M, Bader M, Ganten U, Ganten D . Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol. 1996; 270(6 Pt 1):E919-29. DOI: 10.1152/ajpendo.1996.270.6.E919. View

15.

Mullins J, Peters J, Ganten D . Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990; 344(6266):541-4. DOI: 10.1038/344541a0. View

16.

Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M . Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1999; 84(10):1127-36. DOI: 10.1161/01.res.84.10.1127. View

17.

Ruwhof C, van der Laarse A . Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res. 2000; 47(1):23-37. DOI: 10.1016/s0008-6363(00)00076-6. View

18.

Molkentin J, Dorn 2nd G . Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 2001; 63:391-426. DOI: 10.1146/annurev.physiol.63.1.391. View

19.

Ishikawa M, Saito Y, Miyamoto Y, Harada M, Kuwahara K, Ogawa E . A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens. 1999; 17(6):807-16. DOI: 10.1097/00004872-199917060-00013. View

20.

Pan J, Fukuda K, Kodama H, Sano M, Takahashi T, Makino S . Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels. 1999; 13(4):199-208. DOI: 10.1007/BF01745045. View